No abstract

Herein we present a 63-year-old male patient with a solid hepatic alveolar echinococcosis diagnosed by surgical biopsy. His liver lesion, which was infected, was drained by percutaneous catheterization. The lesion surprisingly disappeared completely after the treatment. The patient was followed-up without any symptoms for 20 months after the drainage. As alveolar echinococcosis of the liver behaves like a slow-growing liver cancer, the disappearance of our patient's lesion was a very unusual and rare outcome, which, to the best of our knowledge, has never been published in the literature.

PurposeThe aim of this study is to determine the involvement of the upper gastrointestinal system (GIS) in patients diagnosed with Crohn's disease (CD), ulcerative colitis (UC), and non-inflammatory bowel disease (IBD) and to compare their differences.MethodsThis study included patients aged between 2 and 18 years who underwent colonoscopy and esophagogastroduodenoscopy (EGD) for the first time due to the prediagnosis of IBD. In EGD, samples were taken from duodenum, antrum, corpus, and esophagus; and gastritis, duodenitis, and esophagitis were identified through histopathologic examination. The data gathered the ends of the research were compared between IBD with non-IBD groups and between CD-UC with non-IBD groups, and the presence of significant differences between groups were determined.ResultsIn our study, 16 patients were diagnosed with CD, 13 with UC, 3 with undeterminate colitis, and 13 with non-IBD. In the histopathological examination of the groups, GIS involvement was found in 94.1% of patients diagnosed with IBD and in 38.5% of non-IBD patients. Moreover, the difference was found to be statistically significant (p=0.032). No significant difference was found between the CD and UC groups. Gastritis was mostly observed in 93.8% of CD-diagnosed patients, 76.8% of UC-diagnosed patients, 81.2% of IBD-diagnosed patients, and 38.5% of non-IBD-diagnosed patients. On the other hand, significant differences were found between CD and non-IBD groups (p=0.03), UC and non-IBD groups (p=0.047), and IBD and non-IBD groups (p=0.03).ConclusionThe results of the study show that gastritis was highly observed in UC- and CD-diagnosed patients than in non-IBD-diagnosed patients.

Although 99mTc red blood cell (RBC) scintigraphy is a very specific method to differentiate a hemangioma from other hepatic masses, several cases of false-positive 99mTc RBC scintigraphy have been previously reported throughout the literature. We report an additional case that presented in a 15-month-old boy with hepatoblastoma showing increased labeled RBC activity mimicking hemangioma.

Amaç:Helicobacter pylori (H. pylori) kronik gastrit, peptik ülser, atrofik gastrit, mide adenokanseri ve lenfoma gelişiminde etiyolojik bir ajandır. Gelişmekte olan ülkelerde prevalansı yüksektir. Çalışma-mızda Antalya bölgesinde histopatolojik olarak H. pylori sıklığının saptanması ve hastaların klinik ve endoskopik bulguları ile eşlik eden atrofi, intestinal metaplazi ve displazi gibi bulguların değerlendiril-mesi amaçlanmıştır. Gereç ve Yöntemler:Çalışmaya değişik endikasyonlarla üst gastrointestinal sistem endoskopisi yapılan ve mide antrum ve korpus biyopsileri alınmış olan 262 hasta alındı. Hastaların patoloji raporları retrospektif olarak incelendi. Histopatolojik olarak H. pylori sıklığı belirlendi ve H. pylori pozitif ve negatif saptanan hastalar endoskopi endikasyonları, endoskopik bulgular ve histopatolojik özellikler açısından karşılaştırıldı. Bulgular:Hastaların %69,5'inde histopatolojik olarak H. pylori pozitifti. H. pylori pozitif grupta yaş ortalaması 46±14,70 yıl olup 104 kadın, 78 erkek hasta vardı. En sık endoskopi endikasyonu dispeptik şikayetlerdi ve H. pylori negatif gruptan farklı değildi (p=0,79). En sık endoskopik bulgu gastritti ve gruplar arasında anlamlı farklılık yoktu (p=0,562). H. pylori pozitif grupta özofajit sıklığı daha düşük, atrofi varlığı ise daha yüksek oranda bulundu ve bu bulgular istatistiksel olarak anlamlıydı (Sırasıyla p=0,02 ve p=0,001). İntestinal metaplazi, displazi açısından anlamlı farklılık bulunmadı (Sırasıyla p=0,118 ve p=0,462). Sonuç: Çalışmamızda özofajit sıklığı H. pylori pozitif hastalarda daha düşük bulunmuş ve bu durum H. pylori'nin gastroözofageal reflü hastalığına karşı koruyucu olabileceği yönündeki çalışmalarla uyumlu olarak değerlendirilmiştir. Atrofi H. pylori pozitif hastalarımızda negatif olanlara göre daha sık bulunmuş, bu bulgu da H. pylori'nin malignite gelişiminde önemli bir etken olduğunu destekler nitelikte olarak değerlendirilmiştir.Anahtar Sözcükler: Helikobakter pylori, Dispepsi, Peptik ülser, Gastroözofageal reflü, Atrofi ABStrAct Objective: Helicobacter pylori (H. pylori) is etiologically associated with chronic gastritis, peptic ulcer, atrophic gastritis, stomach adenocancer and lymphoma. Its prevalence is high in developing countries. In our study, we aimed to detect the prevalence of H. pylori and evaluate the clinical, endoscopic and histopathological findings such as atrophy, intestinal metaplasia and dysplasia in H. pylori positive patients. Material and Methods:262 patients who underwent upper gastrointestinal endoscopy with biopsy from the antrum and corpus were included the study. Pathology reports were evaluated retrospectively. H. pylori prevalence was detected and endoscopy indications, endoscopic and histopathological findings were compared between H. pylori positive and negative groups.